Search clinical trials for: Autologous Transplantation

Total 13111 results

Neurogen Brain and Spine Institute

Withdrawn

Cell Therapy as Treatment for Cerebral Palsy

Cerebral Palsy

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Spinal Cord Injury

Spinal Cord Injury

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy

India
Neurogen Brain and Spine Institute

Withdrawn

Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke

Cerebrovascular Accident

India
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Leukemia

United States
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Autism Spectrum Disorders

Autism Spectrum Disorders

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy for Cerebral Palsy

Cerebral Palsy

India
Neurogen Brain and Spine Institute

Withdrawn

Stem Cell Therapy in Traumatic Brain Injury

Traumatic Brain Injury

India
Mingzhi Zhang

Unknown

Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL

ALK-Positive Anaplastic Large Cell Lymphoma

China
Medical College of Wisconsin

Completed

Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

Multiple Myeloma

United States
University Hospital, Brest

Completed

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure (ZAPA)

Multiple Myeloma | Hodgkin Lymphoma | Non-hodgkin Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
Hospices Civils de Lyon

Completed

Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era

Patient's Outcome Prognostic Factors

France
Northwestern University

Terminated

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Myasthenia Gravis

United States
Northwestern University

Terminated

Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis

Sarcoidosis

United States
Maria Sklodowska-Curie National Research Institute...

Completed

Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.

Multiple Myeloma

Poland
Sun Yat-sen University

Unknown

Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.

Repetition Failure
Henrik Gregersen
Nordic Myeloma Study Group

Unknown

Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support (CARFI)

Multiple Myeloma

Finland, Denmark, Sweden, Norway, Lithuania
Montefiore Medical Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Lymphoma

United States
Jaslok Hospital and Research Centre

Terminated

Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease

Parkinson's Disease

India
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer

Testicular Germ Cell Tumor | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Extragonadal Germ Cell Tumor

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

Breast Cancer

United States
Shanghai Changzheng Hospital

Completed

A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

Multiple Myeloma

China
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

Multiple Myeloma | Plasma Cell Myeloma

United States
University of Alabama at Birmingham
Amgen

Completed

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

Multiple Myeloma

United States
Peking University
Peking University International Hospital; Hebei Medical University Fourth Hospital

Unknown

Chidamide Maintenance After Autologous Hematopoietic Stem Cell Transplantation for Relapsed, Refractory or High-risk Lymphoma

Experimental Tumor

China
Northwestern University

Terminated

Hematopoietic Stem Cell Support in Vasculitis

Vasculitis

United States
University of Michigan Rogel Cancer Center
Medical College of Wisconsin

Completed

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

Multiple Myeloma

United States
Peking University

Unknown

Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Lymphoma

China
Sichuan University

Unknown

Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin Lymphoma

Hodgkin Lymphoma | Non-hodgkin Lymphoma
Asan Medical Center

Unknown

Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia

Leukemia, Myeloid

Korea, Republic of
University Hospital, Bonn

Completed

Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children (HIT-REZ-2005)

Ependymomas | Recurrent Brain Tumors | Supratentorial PNETs | Medulloblastomas

Germany
Sichuan University

Unknown

Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma

Lymphoma

China
Mayo Clinic
National Cancer Institute (NCI)

Completed

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

Lymphoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma

Lymphoma

United States
Qingdao Central Hospital
Yake Biotechnology Ltd.

Unknown

CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation

Lymphoma, B-Cell | Leukemia, B-Cell | Minimal Disease, Residual

China
Global Cell Med

Unknown

Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients

Diabetes Complications | Diabetes Mellitus Progression

Bahamas
Stem Cells Arabia

Completed

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus

Glucose Metabolism Disorders | Metabolic Diseases | Immune System Diseases | Autoimmune Diseases | Endocrine System Diseases | Diabetes Mellitus Type 1

Jordan
Mayo Clinic
National Cancer Institute (NCI)

Completed

Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Instituto de Investigacion Sanitaria La Fe

Unknown

Autologous Bone Marrow Stem Cell Ovarian Transplantation to Restore Ovarian Function in Premature Ovarian Failure (ASCOT-2)

Premature Ovarian Failure (POF)

Spain
State Budgetary Healthcare Institution, National...

Unknown

BeEAC Conditioning Regimen in Malignant Lymphoma Subjects With Indications to Autologous Hematopoietic Stem-cell Transplantation (BeEAC-1)

Relapsed/Refractory Malignant Lymphomas

Russian Federation
Dartmouth-Hitchcock Medical Center

Completed

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Lymphoma

United States
Cook MyoSite

Completed

Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study

Urinary Incontinence, Stress

Canada, United Kingdom, Germany
Stem Cells Arabia

Unknown

Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)

Premature Ovarian Failure

Jordan
Stanford University

Terminated

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Lymphoma, Non-Hodgkin | Diffuse Large B-cell Lymphoma (DLBCL) | Lymphoma, B-cell | Malignant Lymphoma, Non-Hodgkin

United States
German CLL Study Group

Completed

Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Germany, Austria
Vaxart

Withdrawn

A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection

Rhinovirus | Upper Respiratory Tract Infection
Heidelberg University

Completed

Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Leukemia

Germany, Switzerland
European Society for Blood and Marrow Transplantation

Completed

EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients (NISSC)

Autoimmune Diseases

France
Universitaire Ziekenhuizen KU Leuven
Fund for Scientific Research, Flanders, Belgium

Unknown

Restoration of the Microbiome Through Superdonor Selection (RESTORE-UC)

Ulcerative Colitis

Belgium

3

Subscribe